PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma
NCT04040491
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Peripheral T-cell Lymphoma
Interventions
DRUG:
PD-1 blocking antibody, chidamide, lenalidomide and gemcitabine
Sponsor
Mingzhi Zhang